286 related articles for article (PubMed ID: 2783358)
21. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
Wagner JL; Hugli TE
Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
[TBL] [Abstract][Full Text] [Related]
22. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
Nuijens JH; Eerenberg-Belmer AJ; Huijbregts CC; Schreuder WO; Felt-Bersma RJ; Abbink JJ; Thijs LG; Hack CE
J Clin Invest; 1989 Aug; 84(2):443-50. PubMed ID: 2668333
[TBL] [Abstract][Full Text] [Related]
23. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
24. Complement activation in systemic sclerosis.
Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
J Clin Lab Immunol; 1990 Jan; 31(1):39-41. PubMed ID: 1966983
[TBL] [Abstract][Full Text] [Related]
25. Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome.
Zilow G; Sturm JA; Rother U; Kirschfink M
Clin Exp Immunol; 1990 Feb; 79(2):151-7. PubMed ID: 2311295
[TBL] [Abstract][Full Text] [Related]
26. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.
Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG
Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997
[TBL] [Abstract][Full Text] [Related]
27. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
[TBL] [Abstract][Full Text] [Related]
28. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
Lockshin MD; Qamar T; Redecha P; Harpel PC
Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
[TBL] [Abstract][Full Text] [Related]
29. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
[TBL] [Abstract][Full Text] [Related]
30. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
[TBL] [Abstract][Full Text] [Related]
32. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
Dofferhoff AS; de Jong HJ; Bom VJ; van der Meer J; Limburg PC; de Vries-Hospers HG; Marrink J; Mulder PO; Weits J
Scand J Infect Dis; 1992; 24(2):197-204. PubMed ID: 1641597
[TBL] [Abstract][Full Text] [Related]
33. Chronological changes in the complement system in sepsis.
Nakae H; Endo S; Inada K; Yoshida M
Surg Today; 1996; 26(4):225-9. PubMed ID: 8727941
[TBL] [Abstract][Full Text] [Related]
34. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
35. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
36. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
37. Anaphylatoxin formation in extracorporeal circuits.
Chenoweth DE
Complement; 1986; 3(3):152-65. PubMed ID: 3492330
[TBL] [Abstract][Full Text] [Related]
38. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
Greer J
Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
[TBL] [Abstract][Full Text] [Related]
39. Relation between complement activation and susceptibility to decompression sickness.
Ward CA; McCullough D; Fraser WD
J Appl Physiol (1985); 1987 Mar; 62(3):1160-6. PubMed ID: 3494726
[TBL] [Abstract][Full Text] [Related]
40. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
